Username

Password

Forgot Password?

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1.500.000 Profiles
More than 1.800 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

Allan Collins

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Chemicals & Drugs

Living Beings

Anatomy

Concepts & Ideas

Drug Dose-Response Relationship

Physiology

Activities & Behaviors

Disorders

Startle Reaction

Sign-in to see full Profile

Network (preview)

Co-Publications
Name
83
Marks, Michael
25
Grady, Sharon
24
Stitzel, Jerry
22
Whiteaker, Paul
18
Wehner, Jeanne
14
Pauly, James
12
McIntosh, Michael
9
Butt, Christopher
9
Picciotto, Marina
8
Tritto, Theresa
7
Salminen, Outi
7
Lester, Henry
7
Labarca, Cesar
6
Miner, LL
5
McCallum, Sarah

Sign-in to see all Coauthors

Publications

TOP 3
McClure-Begley Tristan D; King Nathan M; Collins Allan C; Stitzel Jerry A; Wehner Jeanne M; Butt Christopher M
Acetylcholine-stimulated [3H]GABA release from mouse brain synaptosomes is modulated by alpha4beta2 and alpha4alpha5beta2 nicotinic receptor subtypes.
Collins Allan C; Salminen Outi; Marks Michael J; Whiteaker Paul; Grady Sharon R
The road to discovery of neuronal nicotinic cholinergic receptor subtypes.
Collins Allan C; McQueen Matthew; Ehringer Marissa
Guest editorial. Genes and lung cancer.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Allan Collins (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: McClure-Begley Tristan D; King Nathan M; Collins Allan C; Stitzel Jerry A; Wehner Jeanne M; Butt Christopher M
Acetylcholine-stimulated [3H]GABA release from mouse brain synaptosomes is modulated by alpha4beta2 and alpha4alpha5beta2 nicotinic receptor subtypes.
Molecular pharmacology 2009;75(4):918-26.
2009: Collins Allan C; Salminen Outi; Marks Michael J; Whiteaker Paul; Grady Sharon R
The road to discovery of neuronal nicotinic cholinergic receptor subtypes.
Handbook of experimental pharmacology 2009;(192):85-112.
2008: Collins Allan C; McQueen Matthew; Ehringer Marissa
Guest editorial. Genes and lung cancer.
Human genomics 2008;3(1):3-6.
2008: Gotti Cecilia; Moretti Milena; Meinerz Natalie M; Clementi Francesco; Gaimarri Annalisa; Collins Allan C; Marks Michael J
Partial deletion of the nicotinic cholinergic receptor alpha 4 or beta 2 subunit genes changes the acetylcholine sensitivity of receptor-mediated 86Rb+ efflux in cortex and thalamus and alters relative expression of alpha 4 and beta 2 subunits.
Molecular pharmacology 2008;73(6):1796-807.
2008: Schlaepfer Isabel R; Hoft Nicole R; Collins Allan C; Corley Robin P; Hewitt John K; Hopfer Christian J; Lessem Jeffrey M; McQueen Matthew B; Rhee Soo Hyun; Ehringer Marissa A
The CHRNA5/A3/B4 gene cluster variability as an important determinant of early alcohol and tobacco initiation in young adults.
Biological psychiatry 2008;63(11):1039-46.
2008: Zeiger Joanna S; Haberstick Brett C; Schlaepfer Isabel; Collins Allan C; Corley Robin P; Crowley Thomas J; Hewitt John K; Hopfer Christian J; Lessem Jeffrey; McQueen Matthew B; Rhee Soo Hyun; Ehringer Marissa A
The neuronal nicotinic receptor subunit genes (CHRNA6 and CHRNB3) are associated with subjective responses to tobacco.
Human molecular genetics 2008;17(5):724-34.
2008: Adams C E; Yonchek J C; Zheng L; Collins A C; Stevens K E
Altered hippocampal circuit function in C3H alpha7 null mutant heterozygous mice.
Brain research 2008;1194():138-45.
2007: Grady Sharon R; Salminen Outi; Laverty Duncan C; Whiteaker Paul; McIntosh J Michael; Collins Allan C; Marks Michael J
The subtypes of nicotinic acetylcholine receptors on dopaminergic terminals of mouse striatum.
Biochemical pharmacology 2007;74(8):1235-46.
2007: Brown Robert W B; Collins Allan C; Lindstrom Jon M; Whiteaker Paul
Nicotinic alpha5 subunit deletion locally reduces high-affinity agonist activation without altering nicotinic receptor numbers.
Journal of neurochemistry 2007;103(1):204-15.
2007: Marks Michael J; Meinerz Natalie M; Drago John; Collins Allan C
Gene targeting demonstrates that alpha4 nicotinic acetylcholine receptor subunits contribute to expression of diverse [3H]epibatidine binding sites and components of biphasic 86Rb+ efflux with high and low sensitivity to stimulation by acetylcholine.
Neuropharmacology 2007;53(3):390-405.
2007: Nashmi Raad; Xiao Cheng; Deshpande Purnima; McKinney Sheri; Grady Sharon R; Whiteaker Paul; Huang Qi; McClure-Begley Tristan; Lindstrom Jon M; Labarca Cesar; Collins Allan C; Marks Michael J; Lester Henry A
Chronic nicotine cell specifically upregulates functional alpha 4* nicotinic receptors: basis for both tolerance in midbrain and enhanced long-term potentiation in perforant path.
The Journal of neuroscience : the official journal of the Society for Neuroscience 2007;27(31):8202-18.
2007: Ehringer Marissa A; Clegg Hilary V; Collins Allan C; Corley Robin P; Crowley Thomas; Hewitt John K; Hopfer Christian J; Krauter Kenneth; Lessem Jeffrey; Rhee Soo Hyun; Schlaepfer Isabel; Smolen Andrew; Stallings Michael C; Young Susan E; Zeiger Joanna S
Association of the neuronal nicotinic receptor beta2 subunit gene (CHRNB2) with subjective responses to alcohol and nicotine.
American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics 2007;144B(5):596-604.
2007: Damaj M I; Fonck C; Marks M J; Deshpande P; Labarca C; Lester H A; Collins A C; Martin B R
Genetic approaches identify differential roles for alpha4beta2* nicotinic receptors in acute models of antinociception in mice.
The Journal of pharmacology and experimental therapeutics 2007;321(3):1161-9.
2007: Salminen Outi; Drapeau Jennifer A; McIntosh J Michael; Collins Allan C; Marks Michael J; Grady Sharon R
Pharmacology of alpha-conotoxin MII-sensitive subtypes of nicotinic acetylcholine receptors isolated by breeding of null mutant mice.
Molecular pharmacology 2007;71(6):1563-71.
2007: Booker T K; Butt Christopher M; Wehner Jeanne M; Heinemann Stephen F; Collins Allan C
Decreased anxiety-like behavior in beta3 nicotinic receptor subunit knockout mice.
Pharmacology, biochemistry, and behavior 2007;87(1):146-57.
2007: Matta Shannon G; Balfour David J; Benowitz Neal L; Boyd R Thomas; Buccafusco Jerry J; Caggiula Anthony R; Craig Caroline R; Collins Allan C; Damaj M Imad; Donny Eric C; Gardiner Phillip S; Grady Sharon R; Heberlein Ulrike; Leonard Sherry S; Levin Edward D; Lukas Ronald J; Markou Athina; Marks Michael J; McCallum Sarah E; Parameswaran Neeraja; Perkins Kenneth A; Picciotto Marina R; Quik Maryka; Rose Jed E; Rothenfluh Adrian; Schafer William R; Stolerman Ian P; Tyndale Rachel F; Wehner Jeanne M; Zirger Jeffrey M
Guidelines on nicotine dose selection for in vivo research.
Psychopharmacology 2007;190(3):269-319.
2006: Whiteaker Paul; Cooper John F; Salminen Outi; Marks Michael J; McClure-Begley Tristan D; Brown Robert W B; Collins Allan C; Lindstrom Jon M
Immunolabeling demonstrates the interdependence of mouse brain alpha4 and beta2 nicotinic acetylcholine receptor subunit expression.
The Journal of comparative neurology 2006;499(6):1016-38.
2006: Marks Michael J; Whiteaker Paul; Collins Allan C
Deletion of the alpha7, beta2, or beta4 nicotinic receptor subunit genes identifies highly expressed subtypes with relatively low affinity for [3H]epibatidine.
Molecular pharmacology 2006;70(3):947-59.
2006: McCallum Sarah E; Collins Allan C; Paylor Richard; Marks Michael J
Deletion of the beta 2 nicotinic acetylcholine receptor subunit alters development of tolerance to nicotine and eliminates receptor upregulation.
Psychopharmacology 2006;184(3-4):314-27.
2005: Fonck Carlos; Cohen Bruce N; Nashmi Raad; Whiteaker Paul; Wagenaar Daniel A; Rodrigues-Pinguet Nivalda; Deshpande Purnima; McKinney Sheri; Kwoh Steven; Munoz Jose; Labarca Cesar; Collins Allan C; Marks Michael J; Lester Henry A
Novel seizure phenotype and sleep disruptions in knock-in mice with hypersensitive alpha 4* nicotinic receptors.
The Journal of neuroscience : the official journal of the Society for Neuroscience 2005;25(49):11396-411.
2005: Gotti Cecilia; Moretti Milena; Clementi Francesco; Riganti Loredana; McIntosh J Michael; Collins Allan C; Marks Michael J; Whiteaker Paul
Expression of nigrostriatal alpha 6-containing nicotinic acetylcholine receptors is selectively reduced, but not eliminated, by beta 3 subunit gene deletion.
Molecular pharmacology 2005;67(6):2007-15.
2005: Salminen Outi; Whiteaker Paul; Grady Sharon R; Collins Allan C; McIntosh J Michael; Marks Michael J
The subunit composition and pharmacology of alpha-Conotoxin MII-binding nicotinic acetylcholine receptors studied by a novel membrane-binding assay.
Neuropharmacology 2005;48(5):696-705.
2005: Bowers Barbara J; McClure-Begley Tristan D; Keller Jason J; Paylor Richard; Collins Allan C; Wehner Jeanne M
Deletion of the alpha7 nicotinic receptor subunit gene results in increased sensitivity to several behavioral effects produced by alcohol.
Alcoholism, clinical and experimental research 2005;29(3):295-302.
2005: Butt Christopher M; King Nathan M; Hutton Scott R; Collins Allan C; Stitzel Jerry A
Modulation of nicotine but not ethanol preference by the mouse Chrna4 A529T polymorphism.
Behavioral neuroscience 2005;119(1):26-37.
2004: Tapper Andrew R; McKinney Sheri L; Nashmi Raad; Schwarz Johannes; Deshpande Purnima; Labarca Cesar; Whiteaker Paul; Marks Michael J; Collins Allan C; Lester Henry A
Nicotine activation of alpha4* receptors: sufficient for reward, tolerance, and sensitization.
Science (New York, N.Y.) 2004;306(5698):1029-32.
2004: Salminen Outi; Murphy Karen L; McIntosh J Michael; Drago John; Marks Michael J; Collins Allan C; Grady Sharon R
Subunit composition and pharmacology of two classes of striatal presynaptic nicotinic acetylcholine receptors mediating dopamine release in mice.
Molecular pharmacology 2004;65(6):1526-35.
2004: Marks Michael J; Rowell Peter P; Cao Jian-Zhe; Grady Sharon R; McCallum Sarah E; Collins Allan C
Subsets of acetylcholine-stimulated 86Rb+ efflux and [125I]-epibatidine binding sites in C57BL/6 mouse brain are differentially affected by chronic nicotine treatment.
Neuropharmacology 2004;46(8):1141-57.
2004: Tritto Theresa; McCallum Sarah E; Waddle Satori A; Hutton Scott R; Paylor Richard; Collins Allan C; Marks Michael J
Null mutant analysis of responses to nicotine: deletion of beta2 nicotinic acetylcholine receptor subunit but not alpha7 subunit reduces sensitivity to nicotine-induced locomotor depression and hypothermia.
Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco 2004;6(1):145-58.
2004: Butt Christopher M; King Nathan M; Stitzel Jerry A; Collins Allan C
Interaction of the nicotinic cholinergic system with ethanol withdrawal.
The Journal of pharmacology and experimental therapeutics 2004;308(2):591-9.
2003: Owens Jeremy C; Balogh Seth A; McClure-Begley Tristan D; Butt Christopher M; Labarca Cesar; Lester Henry A; Picciotto Marina R; Wehner Jeanne M; Collins Allan C
Alpha 4 beta 2* nicotinic acetylcholine receptors modulate the effects of ethanol and nicotine on the acoustic startle response.
Alcoholism, clinical and experimental research 2003;27(12):1867-75.
2003: Cui Changhai; Booker T K; Allen Roberta S; Grady Sharon R; Whiteaker Paul; Marks Michael J; Salminen Outi; Tritto Theresa; Butt Christopher M; Allen W R; Stitzel Jerry A; McIntosh J Michael; Boulter Jim; Collins Allan C; Heinemann Stephen F
The beta3 nicotinic receptor subunit: a component of alpha-conotoxin MII-binding nicotinic acetylcholine receptors that modulate dopamine release and related behaviors.
The Journal of neuroscience : the official journal of the Society for Neuroscience 2003;23(35):11045-53.
2003: Lester Henry A; Fonck Carlos; Tapper Andrew R; McKinney Sheri; Damaj M Imad; Balogh Seth; Owens Jeremy; Wehner Jeanne M; Collins Allan C; Labarca Cesar
Hypersensitive knockin mouse strains identify receptors and pathways for nicotine action.
Current opinion in drug discovery & development 2003;6(5):633-9.
2003: Dobelis Peter; Hutton Scott; Lu Ying; Collins Allan C
GABAergic systems modulate nicotinic receptor-mediated seizures in mice.
The Journal of pharmacology and experimental therapeutics 2003;306(3):1159-66.
2003: Butt Christopher M; Hutton Scott R; Stitzel Jerry A; Balogh Seth A; Owens Jeremy C; Collins Allan C
A polymorphism in the alpha4 nicotinic receptor gene (Chrna4) modulates enhancement of nicotinic receptor function by ethanol.
Alcoholism, clinical and experimental research 2003;27(5):733-42.
2003: King Sarah L; Marks Michael J; Grady Sharon R; Caldarone Barbara J; Koren Andrei O; Mukhin Alexey G; Collins Allan C; Picciotto Marina R
Conditional expression in corticothalamic efferents reveals a developmental role for nicotinic acetylcholine receptors in modulation of passive avoidance behavior.
The Journal of neuroscience : the official journal of the Society for Neuroscience 2003;23(9):3837-43.
2003: Quik Maryka; Sum Jocelyn D; Whiteaker Paul; McCallum Sarah E; Marks Michael J; Musachio John; McIntosh J Michael; Collins Allan C; Grady Sharon R
Differential declines in striatal nicotinic receptor subtype function after nigrostriatal damage in mice.
Molecular pharmacology 2003;63(5):1169-79.
2003: Fonck Carlos; Nashmi Raad; Deshpande Purnima; Damaj M Imad; Marks Michael J; Riedel Anett; Schwarz Johannes; Collins Allan C; Labarca Cesar; Lester Henry A
Increased sensitivity to agonist-induced seizures, straub tail, and hippocampal theta rhythm in knock-in mice carrying hypersensitive alpha 4 nicotinic receptors.
The Journal of neuroscience : the official journal of the Society for Neuroscience 2003;23(7):2582-90.
2002: Balogh Seth A; Owens Jeremy C; Butt Christopher M; Wehner Jeanne M; Collins Allan C
Animal models as a tool for studying mechanisms of co-abuse of alcohol and tobacco.
Alcoholism, clinical and experimental research 2002;26(12):1911-4.
2002: Butt Christopher M; Hutton Scott R; Marks Michael J; Collins Allan C
Bovine serum albumin enhances nicotinic acetylcholine receptor function in mouse thalamic synaptosomes.
Journal of neurochemistry 2002;83(1):48-56.
2002: Dobelis Peter; Marks Michael J; Whiteaker Paul; Balogh Seth A; Collins Allan C; Stitzel Jerry A
A polymorphism in the mouse neuronal alpha4 nicotinic receptor subunit results in an alteration in receptor function.
Molecular pharmacology 2002;62(2):334-42.
2002: Mogg Adrian J; Whiteaker Paul; McIntosh J Michael; Marks Michael; Collins Allan C; Wonnacott Susan
Methyllycaconitine is a potent antagonist of alpha-conotoxin-MII-sensitive presynaptic nicotinic acetylcholine receptors in rat striatum.
The Journal of pharmacology and experimental therapeutics 2002;302(1):197-204.
2002: Marks Michael J; Whiteaker Paul; Grady Sharon R; Picciotto Marina R; McIntosh J Michael; Collins Allan C
Characterization of [(125) I]epibatidine binding and nicotinic agonist-mediated (86) Rb(+) efflux in interpeduncular nucleus and inferior colliculus of beta2 null mutant mice.
Journal of neurochemistry 2002;81(5):1102-15.
2002: Grady Sharon R; Murphy Karen L; Cao Jian; Marks Michael J; McIntosh J Michael; Collins Allan C
Characterization of nicotinic agonist-induced [(3)H]dopamine release from synaptosomes prepared from four mouse brain regions.
The Journal of pharmacology and experimental therapeutics 2002;301(2):651-60.
2002: Tritto Theresa; Stitzel Jerry A; Marks Michael J; Romm Elena; Collins Allan C
Variability in response to nicotine in the LSxSS RI strains: potential role of polymorphisms in alpha4 and alpha6 nicotinic receptor genes.
Pharmacogenetics 2002;12(3):197-208.
2002: Whiteaker Paul; Peterson Cyrus G; Xu Wei; McIntosh J Michael; Paylor Richard; Beaudet Arthur L; Collins Allan C; Marks Michael J
Involvement of the alpha3 subunit in central nicotinic binding populations.
The Journal of neuroscience : the official journal of the Society for Neuroscience 2002;22(7):2522-9.
2002: Dukat Malgorzata; Damaj Imad M; Young Richard; Vann Robert; Collins Allan C; Marks Michael J; Martin Billy R; Glennon Richard A
Functional diversity among 5-substituted nicotine analogs; in vitro and in vivo investigations.
European journal of pharmacology 2002;435(2-3):171-80.
2001: Adams C E; Stitzel J A; Collins A C; Freedman R
Alpha7-nicotinic receptor expression and the anatomical organization of hippocampal interneurons.
Brain research 2001;922(2):180-90.
2001: Stevens K E; Bullock A E; Collins A C
Chronic corticosterone treatment alters sensory gating in C3H mice.
Pharmacology, biochemistry, and behavior 2001;69(3-4):359-66.
2001: Tritto T; Marley R J; Bastidas D; Stitzel J A; Collins A C
Potential regulation of nicotine and ethanol actions by alpha4-containing nicotinic receptors.
Alcohol (Fayetteville, N.Y.) 2001;24(2):69-78.
2001: Stitzel J A; Dobelis P; Jimenez M; Collins A C
Long sleep and short sleep mice differ in nicotine-stimulated 86Rb+ efflux and alpha4 nicotinic receptor subunit cDNA sequence.
Pharmacogenetics 2001;11(4):331-9.
2001: Vissel B; Royle G A; Christie B R; Schiffer H H; Ghetti A; Tritto T; Perez-Otano I; Radcliffe R A; Seamans J; Sejnowski T; Wehner J M; Collins A C; O'Gorman S; Heinemann S F
The role of RNA editing of kainate receptors in synaptic plasticity and seizures.
Neuron 2001;29(1):217-27.
2001: Grady S R; Meinerz N M; Cao J; Reynolds A M; Picciotto M R; Changeux J P; McIntosh J M; Marks M J; Collins A C
Nicotinic agonists stimulate acetylcholine release from mouse interpeduncular nucleus: a function mediated by a different nAChR than dopamine release from striatum.
Journal of neurochemistry 2001;76(1):258-68.
2000: Marks M J; Stitzel J A; Grady S R; Picciotto M R; Changeux J P; Collins A C
Nicotinic-agonist stimulated (86)Rb(+) efflux and [(3)H]epibatidine binding of mice differing in beta2 genotype.
Neuropharmacology 2000;39(13):2632-45.
2000: Whiteaker P; Jimenez M; McIntosh J M; Collins A C; Marks M J
Identification of a novel nicotinic binding site in mouse brain using [(125)I]-epibatidine.
British journal of pharmacology 2000;131(4):729-39.
2000: Breese C R; Lee M J; Adams C E; Sullivan B; Logel J; Gillen K M; Marks M J; Collins A C; Leonard S
Abnormal regulation of high affinity nicotinic receptors in subjects with schizophrenia.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2000;23(4):351-64.
2000: Stitzel J A; Lu Y; Jimenez M; Tritto T; Collins A C
Genetic and pharmacological strategies identify a behavioral function of neuronal nicotinic receptors.
Behavioural brain research 2000;113(1-2):57-64.
2000: Whiteaker P; McIntosh J M; Luo S; Collins A C; Marks M J
125I-alpha-conotoxin MII identifies a novel nicotinic acetylcholine receptor population in mouse brain.
Molecular pharmacology 2000;57(5):913-25.
2000: Sharples C G; Kaiser S; Soliakov L; Marks M J; Collins A C; Washburn M; Wright E; Spencer J A; Gallagher T; Whiteaker P; Wonnacott S
UB-165: a novel nicotinic agonist with subtype selectivity implicates the alpha4beta2* subtype in the modulation of dopamine release from rat striatal synaptosomes.
The Journal of neuroscience : the official journal of the Society for Neuroscience 2000;20(8):2783-91.
2000: Stitzel J A; Jimenez M; Marks M J; Tritto T; Collins A C
Potential role of the alpha4 and alpha6 nicotinic receptor subunits in regulating nicotine-induced seizures.
The Journal of pharmacology and experimental therapeutics 2000;293(1):67-74.
2000: Bowers B J; Collins A C; Tritto T; Wehner J M
Mice lacking PKC gamma exhibit decreased anxiety.
Behavior genetics 2000;30(2):111-21.
2000: Whiteaker P; Marks M J; Grady S R; Lu Y; Picciotto M R; Changeux J P; Collins A C
Pharmacological and null mutation approaches reveal nicotinic receptor diversity.
European journal of pharmacology 2000;393(1-3):123-35.
1999: Lu Y; Marks M J; Collins A C
Desensitization of nicotinic agonist-induced [3H]gamma-aminobutyric acid release from mouse brain synaptosomes is produced by subactivating concentrations of agonists.
The Journal of pharmacology and experimental therapeutics 1999;291(3):1127-34.
1999: Whiteaker P; Davies A R; Marks M J; Blagbrough I S; Potter B V; Wolstenholme A J; Collins A C; Wonnacott S
An autoradiographic study of the distribution of binding sites for the novel alpha7-selective nicotinic radioligand [3H]-methyllycaconitine in the mouse brain.
The European journal of neuroscience 1999;11(8):2689-96.
1999: Marks M J; Whiteaker P; Calcaterra J; Stitzel J A; Bullock A E; Grady S R; Picciotto M R; Changeux J P; Collins A C
Two pharmacologically distinct components of nicotinic receptor-mediated rubidium efflux in mouse brain require the beta2 subunit.
The Journal of pharmacology and experimental therapeutics 1999;289(2):1090-103.
1999: Bowers B J; Owen E H; Collins A C; Abeliovich A; Tonegawa S; Wehner J M
Decreased ethanol sensitivity and tolerance development in gamma-protein kinase C null mutant mice is dependent on genetic background.
Alcoholism, clinical and experimental research 1999;23(3):387-97.
1998: Lu Y; Grady S; Marks M J; Picciotto M; Changeux J P; Collins A C
Pharmacological characterization of nicotinic receptor-stimulated GABA release from mouse brain synaptosomes.
The Journal of pharmacology and experimental therapeutics 1998;287(2):648-57.
1998: Booker T K; Smith K W; Dodrill C; Collins A C
Calcium modulation of activation and desensitization of nicotinic receptors from mouse brain.
Journal of neurochemistry 1998;71(4):1490-500.
1998: Rogers S W; Gahring L C; Collins A C; Marks M
Age-related changes in neuronal nicotinic acetylcholine receptor subunit alpha4 expression are modified by long-term nicotine administration.
The Journal of neuroscience : the official journal of the Society for Neuroscience 1998;18(13):4825-32.
1998: Marks M J; Smith K W; Collins A C
Differential agonist inhibition identifies multiple epibatidine binding sites in mouse brain.
The Journal of pharmacology and experimental therapeutics 1998;285(1):377-86.
1998: Stitzel J A; Blanchette J M; Collins A C
Sensitivity to the seizure-inducing effects of nicotine is associated with strain-specific variants of the alpha 5 and alpha 7 nicotinic receptor subunit genes.
The Journal of pharmacology and experimental therapeutics 1998;284(3):1104-11.
1997: Bullock A E; Slobe B S; Vázquez V; Collins A C
Inbred mouse strains differ in the regulation of startle and prepulse inhibition of the startle response.
Behavioral neuroscience 1997;111(6):1353-60.
1997: Damaj M I; Glassco W; Marks M J; Slobe B; James J R; May E L; Rosecrans J A; Collins A C; Martin B R
Pharmacological investigation of (+)- and (-)-cis-2,3,3a,4,5,9b-hexahydro-1-methyl-1H-pyrrolo-[3,2-h]isoq uinoline, a bridged-nicotine analog.
The Journal of pharmacology and experimental therapeutics 1997;282(3):1425-34.
1997: Grady S R; Grun E U; Marks M J; Collins A C
Pharmacological comparison of transient and persistent [3H]dopamine release from mouse striatal synaptosomes and response to chronic L-nicotine treatment.
The Journal of pharmacology and experimental therapeutics 1997;282(1):32-43.
1997: Breese C R; Marks M J; Logel J; Adams C E; Sullivan B; Collins A C; Leonard S
Effect of smoking history on [3H]nicotine binding in human postmortem brain.
The Journal of pharmacology and experimental therapeutics 1997;282(1):7-13.
1997: Bullock A E; Clark A L; Grady S R; Robinson S F; Slobe B S; Marks M J; Collins A C
Neurosteroids modulate nicotinic receptor function in mouse striatal and thalamic synaptosomes.
Journal of neurochemistry 1997;68(6):2412-23.
1997: Booker T K; Collins A C
Long-term ethanol treatment elicits changes in nicotinic receptor binding in only a few brain regions.
Alcohol (Fayetteville, N.Y.) 1997;14(2):131-40.
1996: Stitzel J A; Farnham D A; Collins A C
Linkage of strain-specific nicotinic receptor alpha 7 subunit restriction fragment length polymorphisms with levels of alpha-bungarotoxin binding in brain.
Brain research. Molecular brain research 1996;43(1-2):30-40.
1996: Collins A C; Wilkins L H; Slobe B S; Cao J Z; Bullock A E
Long-term ethanol and nicotine treatment elicit tolerance to ethanol.
Alcoholism, clinical and experimental research 1996;20(6):990-9.
1996: Marks M J; Pauly J R; Grun E U; Collins A C
ST/b and DBA/2 mice differ in brain alpha-bungarotoxin binding and alpha 7 nicotinic receptor subunit mRNA levels: a quantitative autoradiographic analysis.
Brain research. Molecular brain research 1996;39(1-2):207-22.
1996: Pauly J R; Marks M J; Robinson S F; van de Kamp J L; Collins A C
Chronic nicotine and mecamylamine treatment increase brain nicotinic receptor binding without changing alpha 4 or beta 2 mRNA levels.
The Journal of pharmacology and experimental therapeutics 1996;278(1):361-9.
1996: Robinson S F; Grun E U; Pauly J R; Collins A C
Changes in sensitivity to nicotine and brain nicotinic receptors following chronic nicotine and corticosterone treatments in mice.
Pharmacology, biochemistry, and behavior 1996;54(3):587-93.
1996: Stitzel J A; Farnham D A; Collins A C
Chronic corticosterone treatment elicits dose-dependent changes in mouse brain alpha-bungarotoxin binding.
Neuroscience 1996;72(3):791-9.
1996: Marks M J; Robinson S F; Collins A C
Nicotinic agonists differ in activation and desensitization of 86Rb+ efflux from mouse thalamic synaptosomes.
The Journal of pharmacology and experimental therapeutics 1996;277(3):1383-96.
1996: Wilson W R; Collins A C
Different levels of [3H]MK-801 binding in long-sleep and short-sleep lines of mice.
Alcohol (Fayetteville, N.Y.) 1996;13(3):315-20.
1996: Christensen S C; Johnson T E; Markel P D; Clark V J; Fulker D W; Corley R P; Collins A C; Wehner J M
Quantitative trait locus analyses of sleep-times induced by sedative-hypnotics in LSXSS recombinant inbred strains of mice.
Alcoholism, clinical and experimental research 1996;20(3):543-50.
1996: Robinson S F; Marks M J; Collins A C
Inbred mouse strains vary in oral self-selection of nicotine.
Psychopharmacology 1996;124(4):332-9.
1995: Grun E U; Pauly J R; Bullock A E; Collins A C
Corticosterone reversibly alters brain alpha-bungarotoxin binding and nicotine sensitivity.
Pharmacology, biochemistry, and behavior 1995;52(3):629-35.
1995: Marks M J; Bullock A E; Collins A C
Sodium channel blockers partially inhibit nicotine-stimulated 86Rb+ efflux from mouse brain synaptosomes.
The Journal of pharmacology and experimental therapeutics 1995;274(2):833-41.
1995: Cao W; Wehner J M; Collins A C
Chronic intragastric infusion produces tolerance to ethanol in LS and SS mice.
Alcohol (Fayetteville, N.Y.) 1995;12(3):241-6.
1994: Marks M J; Grady S R; Yang J M; Lippiello P M; Collins A C
Desensitization of nicotine-stimulated 86Rb+ efflux from mouse brain synaptosomes.
Journal of neurochemistry 1994;63(6):2125-35.
1994: Collins A C; Luo Y; Selvaag S; Marks M J
Sensitivity to nicotine and brain nicotinic receptors are altered by chronic nicotine and mecamylamine infusion.
The Journal of pharmacology and experimental therapeutics 1994;271(1):125-33.
1994: de Fiebre N C; de Fiebre C M; Booker T K; Nelson S; Collins A C
Bioavailability of ethanol is reduced in several commonly used liquid diets.
Alcohol (Fayetteville, N.Y.) 1994;11(4):329-35.
1994: Robinson S F; Pauly J R; Marks M J; Collins A C
An analysis of response to nicotine infusion using an automated radiotelemetry system.
Psychopharmacology 1994;115(1-2):115-20.
1994: Grady S R; Marks M J; Collins A C
Desensitization of nicotine-stimulated [3H]dopamine release from mouse striatal synaptosomes.
Journal of neurochemistry 1994;62(4):1390-8.
1994: van de Kamp J L; Collins A C
Prenatal nicotine alters nicotinic receptor development in the mouse brain.
Pharmacology, biochemistry, and behavior 1994;47(4):889-900.
1994: Luo Y; Marks M J; Collins A C
Genotype regulates the development of tolerance to ethanol and cross-tolerance to nicotine.
Alcohol (Fayetteville, N.Y.) 1994;11(2):167-76.
1994: Bhat R V; Marks M J; Collins A C
Effects of chronic nicotine infusion on kinetics of high-affinity nicotine binding.
Journal of neurochemistry 1994;62(2):574-81.
1993: Cao W; Collins A C
Ethanol effects on 2-deoxyglucose uptake into tissues obtained from LS and SS mice.
Alcohol (Fayetteville, N.Y.) 1993;10(6):521-7.
1993: de Fiebre C M; Collins A C
A comparison of the development of tolerance to ethanol and cross-tolerance to nicotine after chronic ethanol treatment in long- and short-sleep mice.
The Journal of pharmacology and experimental therapeutics 1993;266(3):1398-406.
1993: Collins A C; Romm E; Selvaag S; Turner S; Marks M J
A comparison of the effects of chronic nicotine infusion on tolerance to nicotine and cross-tolerance to ethanol in long- and short-sleep mice.
The Journal of pharmacology and experimental therapeutics 1993;266(3):1390-7.
1993: Marks M J; Grady S R; Collins A C
Downregulation of nicotinic receptor function after chronic nicotine infusion.
The Journal of pharmacology and experimental therapeutics 1993;266(3):1268-76.
1993: Cao W; Burkholder T; Wilkins L; Collins A C
A genetic comparison of behavioral actions of ethanol and nicotine in the mirrored chamber.
Pharmacology, biochemistry, and behavior 1993;45(4):803-9.
1993: Pauly J R; Robinson S F; Collins A C
Chronic corticosterone administration enhances behavioral sensitization to amphetamine in mice.
Brain research 1993;620(2):195-202.
1993: Marks M J; Farnham D A; Grady S R; Collins A C
Nicotinic receptor function determined by stimulation of rubidium efflux from mouse brain synaptosomes.
The Journal of pharmacology and experimental therapeutics 1993;264(2):542-52.
1993: Pauly J R; Collins A C
An autoradiographic analysis of alterations in nicotinic cholinergic receptors following 1 week of corticosterone supplementation.
Neuroendocrinology 1993;57(2):262-71.
1992: De Fiebre N C; Marley R J; Wehner J M; Collins A C
Lipid solubility of sedative-hypnotic drugs influences hypothermic and hypnotic responses of long-sleep and short-sleep mice.
The Journal of pharmacology and experimental therapeutics 1992;263(1):232-40.
1992: Grady S; Marks M J; Wonnacott S; Collins A C
Characterization of nicotinic receptor-mediated [3H]dopamine release from synaptosomes prepared from mouse striatum.
Journal of neurochemistry 1992;59(3):848-56.
1992: Wehner J M; Pounder J I; Parham C; Collins A C
A recombinant inbred strain analysis of sleep-time responses to several sedative-hypnotics.
Alcoholism, clinical and experimental research 1992;16(3):522-8.
1992: de Fiebre C M; Marley R J; Miner L L; de Fiebre N E; Wehner J M; Collins A C
Classical genetic analyses of responses to sedative-hypnotic drugs in crosses derived from long-sleep and short-sleep mice.
Alcoholism, clinical and experimental research 1992;16(3):511-21.
1992: Van de Kamp J L; Collins A C
Species differences in diisopropylfluorophosphate-induced decreases in the number of brain nicotinic receptors.
Pharmacology, biochemistry, and behavior 1992;42(1):131-41.
1992: de Fiebre C M; Collins A C
Classical genetic analyses of responses to nicotine and ethanol in crosses derived from long- and short-sleep mice.
The Journal of pharmacology and experimental therapeutics 1992;261(1):173-80.
1992: Pauly J R; Grun E U; Collins A C
Tolerance to nicotine following chronic treatment by injections: a potential role for corticosterone.
Psychopharmacology 1992;108(1-2):33-9.
1991: Marks M J; Campbell S M; Romm E; Collins A C
Genotype influences the development of tolerance to nicotine in the mouse.
The Journal of pharmacology and experimental therapeutics 1991;259(1):392-402.
1991: Pauly J R; Marks M J; Gross S D; Collins A C
An autoradiographic analysis of cholinergic receptors in mouse brain after chronic nicotine treatment.
The Journal of pharmacology and experimental therapeutics 1991;258(3):1127-36.
1991: Bhat R V; Turner S L; Selvaag S R; Marks M J; Collins A C
Regulation of brain nicotinic receptors by chronic agonist infusion.
Journal of neurochemistry 1991;56(6):1932-9.
1990: Bhat R V; Turner S L; Marks M J; Collins A C
Selective changes in sensitivity to cholinergic agonists and receptor changes elicited by continuous physostigmine infusion.
The Journal of pharmacology and experimental therapeutics 1990;255(1):187-96.
1990: Collins A C; Romm E; Wehner J M
Dissociation of the apparent relationship between nicotine tolerance and up-regulation of nicotinic receptors.
Brain research bulletin 1990;25(3):373-9.
1990: Freund R K; Luntz-Leybman V; Collins A C
Nicotine interferes with GABA-mediated inhibitory processes in mouse hippocampus.
Brain research 1990;527(2):286-91.
1990: Luntz-Leybman V; Freund R K; Collins A C
5 alpha-Pregnan-3 alpha-ol-20-one blocks nicotine-induced seizures and enhances paired-pulse inhibition.
European journal of pharmacology 1990;185(2-3):239-42.
1990: Collins A C; Campbell S M; Romm E; Marks M J
A comparison of sensitivity to oxotremorine and muscarinic receptors in LS and SS mice.
Alcoholism, clinical and experimental research 1990;14(4):605-15.
1990: de Fiebre C M; Marks M J; Collins A C
Ethanol-nicotine interactions in long-sleep and short-sleep mice.
Alcohol (Fayetteville, N.Y.) 1990;7(3):249-57.
1990: Freund R K; Jungschaffer D A; Collins A C
Nicotine effects in mouse hippocampus are blocked by mecamylamine, but not other nicotinic antagonists.
Brain research 1990;511(2):187-91.
1990: Pauly J R; Ullman E A; Collins A C
Strain differences in adrenalectomy-induced alterations in nicotine sensitivity in the mouse.
Pharmacology, biochemistry, and behavior 1990;35(1):171-9.
1990: Pauly J R; Grün E U; Collins A C
Chronic corticosterone administration modulates nicotine sensitivity and brain nicotinic receptor binding in C3H mice.
Psychopharmacology 1990;101(3):310-6.
1990: Romm E; Lippiello P M; Marks M J; Collins A C
Purification of L-[3H]nicotine eliminates low affinity binding.
Life sciences 1990;46(13):935-43.
1990: Fiedler E P; Marks M J; Collins A C
Postnatal development of two nicotinic cholinergic receptors in seven mouse brain regions.
International journal of developmental neuroscience : the official journal of the International Society for Developmental Neuroscience 1990;8(5):533-40.
1990: Collins A C; Bhat R V; Pauly J R; Marks M J
Modulation of nicotine receptors by chronic exposure to nicotinic agonists and antagonists.
Ciba Foundation symposium 1990;152():68-82; discussion 82-6.
1989: de Fiebre C M; Ruth J A; Collins A C
Differential sensitivity of long-sleep and short-sleep mice to high doses of cocaine.
Pharmacology, biochemistry, and behavior 1989;34(4):887-93.
1989: Marks M J; Romm E; Campbell S M; Collins A C
Variation of nicotinic binding sites among inbred strains.
Pharmacology, biochemistry, and behavior 1989;33(3):679-89.
1989: Marks M J; Stitzel J A; Collins A C
Genetic influences on nicotine responses.
Pharmacology, biochemistry, and behavior 1989;33(3):667-78.
1989: Miner L L; Collins A C
Strain comparison of nicotine-induced seizure sensitivity and nicotinic receptors.
Pharmacology, biochemistry, and behavior 1989;33(2):469-75.
1989: Pauly J R; Stitzel J A; Marks M J; Collins A C
An autoradiographic analysis of cholinergic receptors in mouse brain.
Brain research bulletin 1989;22(2):453-9.
1989: de Fiebre C M; Collins A C
Behavioral desensitization to nicotine is enhanced differentially by ethanol in long-sleep and short-sleep mice.
Alcohol (Fayetteville, N.Y.) 1989;6(1):45-51.
1988: Freund R K; Martin B J; Jungschaffer D A; Ullman E A; Collins A C
Genetic differences in plasma corticosterone levels in response to nicotine injection.
Pharmacology, biochemistry, and behavior 1988;30(4):1059-64.
1988: Freund R K; Jungschaffer D A; Collins A C; Wehner J M
Evidence for modulation of GABAergic neurotransmission by nicotine.
Brain research 1988;453(1-2):215-20.
1988: Collins A C; Miner L L; Marks M J
Genetic influences on acute responses to nicotine and nicotine tolerance in the mouse.
Pharmacology, biochemistry, and behavior 1988;30(1):269-78.
1988: Stitzel J A; Campbell S M; Collins A C; Marks M J
Sulfhydryl modification of two nicotinic binding sites in mouse brain.
Journal of neurochemistry 1988;50(3):920-8.
1988: Miner L L; Collins A C
Effect of nicotine pretreatment on nicotine-induced seizures.
Pharmacology, biochemistry, and behavior 1988;29(2):375-80.
1988: Collins A C; Burch J B; de Fiebre C M; Marks M J
Tolerance to and cross tolerance between ethanol and nicotine.
Pharmacology, biochemistry, and behavior 1988;29(2):365-73.
1988: de Fiebre C M; Collins A C
Decreased sensitivity to nicotine-induced seizures as a consequence of nicotine pretreatment in long-sleep and short-sleep mice.
Alcohol (Fayetteville, N.Y.) 1988;5(1):55-61.
1988: Ruth J A; Ullman E A; Collins A C
An analysis of cocaine effects on locomotor activities and heart rate in four inbred mouse strains.
Pharmacology, biochemistry, and behavior 1988;29(1):157-62.
1988: Pauly J R; Ullman E A; Collins A C
Adrenocortical hormone regulation of nicotine sensitivity in mice.
Physiology & behavior 1988;44(1):109-16.
1988: Collins A C; Romm E; Wehner J M
Nicotine tolerance: an analysis of the time course of its development and loss in the rat.
Psychopharmacology 1988;96(1):7-14.
1988: Burch J B; de Fiebre C M; Marks M J; Collins A C
Chronic ethanol or nicotine treatment results in partial cross-tolerance between these agents.
Psychopharmacology 1988;95(4):452-8.
1988: Miner L L; Collins A C
The effect of chronic nicotine treatment on nicotine-induced seizures.
Psychopharmacology 1988;95(1):52-5.
1987: De Fiebre C M; Medhurst L J; Collins A C
Nicotine response and nicotinic receptors in long-sleep and short-sleep mice.
Alcohol (Fayetteville, N.Y.) 1987;4(6):493-501.
1987: Marks M J; Romm E; Collins A C
Mouse brain ATPase activities after chronic nicotine infusion.
Biochemical pharmacology 1987;36(19):3318-20.
1987: Marks M J; Romm E; Collins A C
Genetic influences on tolerance development with chronic oxotremorine infusion.
Pharmacology, biochemistry, and behavior 1987;27(4):723-32.
1987: Marks M J; Stitzel J A; Collins A C
Influence of kinetics of nicotine administration on tolerance development and receptor levels.
Pharmacology, biochemistry, and behavior 1987;27(3):505-12.
1986: Marks M J; Stitzel J A; Collins A C
Dose-response analysis of nicotine tolerance and receptor changes in two inbred mouse strains.
The Journal of pharmacology and experimental therapeutics 1986;239(2):358-64.
1986: Marks M J; Stitzel J A; Romm E; Wehner J M; Collins A C
Nicotinic binding sites in rat and mouse brain: comparison of acetylcholine, nicotine, and alpha-bungarotoxin.
Molecular pharmacology 1986;30(5):427-36.
1986: Marley R J; Miner L L; Wehner J M; Collins A C
Differential effects of central nervous system depressants in long-sleep and short-sleep mice.
The Journal of pharmacology and experimental therapeutics 1986;238(3):1028-33.
1986: Marks M J; Romm E; Gaffney D K; Collins A C
Nicotine-induced tolerance and receptor changes in four mouse strains.
The Journal of pharmacology and experimental therapeutics 1986;237(3):809-19.
1985: Marks M J; Stitzel J A; Collins A C
Time course study of the effects of chronic nicotine infusion on drug response and brain receptors.
The Journal of pharmacology and experimental therapeutics 1985;235(3):619-28.
1985: Marks M J; Romm E; Bealer S M; Collins A C
A test battery for measuring nicotine effects in mice.
Pharmacology, biochemistry, and behavior 1985;23(2):325-30.

Sign-in to see more